image

The best stocks to buy since 1993

Latest issue now available

HeiQ - Making some interesting 'bets' in the medical textile space

March 2021

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • HEIQ
  • Price:
  • 200p
HeiQ was briefly covered in January. It is a material innovation company that develops functional textile technologies - so in the main it is selling chemicals or scrim fabric linings that are applied to textiles to give them certain properties - such as antiviral, odour control, water repellence or warming or cooling properties.  The shares have traded strongly since the company joined the Full List last November as investors anticipated accelerated demand for its antimicrobial treatment for fabric, HeiQ Viroblock, which can reduce viral activity on any material. The company claims that Viroblock has been tested 99.99% effective in 30 minutes against SARS-CoV-2, the Covid-19 causing virus. Capitalizing on consumers’ fear of germs, ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe